Published in Law and Health Weekly, January 22nd, 2005
Bavarian Nordic A/S sets up a holding company in the USA, Bavarian Nordic, Inc., which based in Delaware will serve as legal entity for future activities in the U.S.
Furthermore, Bavarian Nordic A/S establishes an operating company, BN ImmunoTherapeutics, Inc., for research and development of cancer vaccines, initially against breast, prostate and colon cancers. BN ImmunoTherapeutics will have its base in the Palo Alto area of California and scientific activities are expected to begin in January 2005.
Bavarian Nordic A/S will...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.